India to Sudan: Streptomycin Export Trade Route

The India to Sudan Streptomycin corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $7.2K USD. The route is dominated by S. HIMATLAL HEALTHCARE LLP , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's streptomycin manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $3.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with streptomycin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 14.1%, placing it at rank #7 among India's top streptomycin export destinations globally.

On the import side, key buyers of Indian streptomycin in Sudan include TO THE ORDER OF . TO THE ORDER OF is the single largest importer with 2 shipments valued at $7.2K USD.

India's streptomycin exports to Sudan are driven primarily by a handful of large-scale manufacturers. S. HIMATLAL HEALTHCARE LLP with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Sudan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — S. HIMATLAL HEALTHCARE LLP — together account for 100% of total trade value on this route. The average shipment value of $3.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, TO THE ORDER OF is the largest importer with 2 shipments worth $7.2K USD — representing 100% of all streptomycin imports from India on this route.